|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,200 KRW | -1.12% |
|
-6.58% | +10.66% |
| Mar. 15 | Sonid Inc. announced that it expects to receive KRW 3 billion in funding | CI |
| 2023 | MEDICOX Co., Ltd. announced that it has received KRW 8.000000256 billion in funding from Sonid Inc. | CI |
On January 14, 2021, Immunomic Therapeutics, Inc. closed the transaction. The company amended the terms of the transaction. On the same day, the company has received $16,428,230 in its third tranche, bringing total funding raised in the transaction to $77,728,230.
The transaction included participation from 6 investors.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 111,200 KRW | +1.65% | +4.61% | 10.49B | ||
| 6,750 KRW | -1.89% | -7.53% | 222M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +10.66% | 63.29M | |
| +1.20% | 67.6B | |
| +44.29% | 40.33B | |
| +15.99% | 38.65B | |
| +4.67% | 32.55B | |
| +6.59% | 18.94B | |
| +12.32% | 16.76B | |
| +17.69% | 15.07B | |
| +8.31% | 14.83B | |
| -14.74% | 13.79B |
SONID INC. 
